How Value Analysis Committees’ Lines of Questioning Can Directly Affect Value Equation Outputs
John Kelty from W.L. Gore & Associates discusses how value analysis committees can determine a medical devices value when evaluating new products.
Related Resources
Webcast
It doesn’t take a deadly pandemic like Ebola to put your supply chain—and your staff and patients--at risk. Flu outbreaks cause sudden s
Webcast
Teresa Dail, chief supply chain officer, VUMC and 2018 AHRMM board chair, shares AHRMM’s definition of clinical integration and why a clinical
Toolkits/Methodology
As health care organizations evolve, their strategies to include population health, the total cost, episode and subsequently value of care pr
Case Studies
AHRMM is building a repository for leading and proven supply chain practices, case studies, and toolkits that are developed from a
White Papers
In an effort to capture broader insights on UDI adoption from across the health care field, AHRMM, with participation by the FDA, held LUC Dat